Palo Alto, CA, United States of America

Robert L Spraggins

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 1976.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,307 
Other
 patents

Years Active: 1976

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Robert L. Spraggins

Introduction

Robert L. Spraggins is a notable inventor based in Palo Alto, California. He has made significant contributions to the field of chemistry, particularly in the development of novel compounds derived from coral. His work has implications for both antibacterial agents and biologically active prostaglandins.

Latest Patents

Spraggins holds a patent for "Novel compounds from coral," which includes compounds of the formula ##SPC1##. In this formula, R.sub.1 can be hydrogen or methyl, while R.sub.2 can be hydrogen or acetyl, along with the diester thereof. These compounds are recognized for their potential as intermediates in the preparation of biologically active prostaglandins and as effective antibacterial agents. He has 1 patent to his name.

Career Highlights

Throughout his career, Spraggins has focused on innovative research that bridges the gap between natural compounds and their applications in medicine. His work exemplifies the intersection of chemistry and biology, showcasing how natural resources can lead to significant advancements in healthcare.

Collaborations

One of his notable collaborators is Alfred J. Weinheimer. Together, they have explored various aspects of chemical compounds and their potential uses in medical applications.

Conclusion

Robert L. Spraggins is a distinguished inventor whose work on novel compounds from coral has opened new avenues in the field of medicinal chemistry. His contributions continue to influence research and development in antibacterial agents and biologically active compounds.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…